Optimized detection of homologous recombination deficiency improves the prediction of clinical outcomes in cancer

Fernando Ramon Perez Villatoro; Jaana Oikkonen; Julia Casado; Anastasiya Chernenko; Doga C. Gulhan; Manuela Tumiati; Yilin  Li; Kari Antero Lavikka; Sakari Hietanen; Johanna Hynninen; Ulla-Maija Haltia; Jaakko S. Tyrmi; Hannele Laivuori; Panagiotis A. Konstantinopoulos; Sampsa Hautaniemi; Liisa Kauppi; Anniina Färkkilä

doi:10.1038/s41698-022-00339-8

Optimized detection of homologous recombination deficiency improves the prediction of clinical outcomes in cancer

Fernando Ramon Perez Villatoro, Jaana Oikkonen, Julia Casado, Anastasiya Chernenko, Doga C. Gulhan, Manuela Tumiati, Yilin Li, Kari Antero Lavikka, Sakari Hietanen, Johanna Hynninen, Ulla-Maija Haltia, Jaakko S. Tyrmi, Hannele Laivuori, Panagiotis A. Konstantinopoulos, Sampsa Hautaniemi, Liisa Kauppi, Anniina Färkkilä

Research output: Contribution to journal › Article › Scientific › peer-review

Original language	English
Article number	96
Journal	npj precision oncology
Volume	6
Issue number	1
Number of pages	13
ISSN	2397-768X
DOIs	https://doi.org/10.1038/s41698-022-00339-8
Publication status	Published - 2022
MoE publication type	A1 Journal article-refereed

Fields of Science

3122 Cancers

Access to Document

10.1038/s41698-022-00339-8

s41698_022_00339_8Final published version, 3.86 MBLicence: CC BY

Discovery and therapeutic exploitation of immunological vulnerabilities in ovarian cancer
Färkkilä, A. (Project manager), Casado, J. (Participant), Perez Villatoro, F. R. (Participant), Pietilä, E. (Participant), Nagaraj, A. (Participant) & Launonen, I.-M. P. (Participant)
SUOMEN AKATEMIA
01/01/2021 → 31/12/2024
Project: University of Helsinki Three-Year Research Project
Discovery and therapeutic exploitation of immunological vulnerabilities in ovarian cancer
Färkkilä, A. (Project manager), Kang, Z. (Participant), Niemiec, I. (Participant), Nagaraj, A. (Participant), Perez Villatoro, F. R. (Participant), Chernenko, A. (Participant) & Shah, S. (Participant)
01/01/2021 → 31/12/2023
Project: University of Helsinki Three-Year Research Project

iCAN Ovarian Cancer Subproject coordinator
Färkkilä, A. (Participant)
2021 → …
Activity: Other activity types › Other

Cite this

Perez Villatoro, F. R., Oikkonen, J., Casado, J., Chernenko, A., Gulhan, D. C., Tumiati, M., Li, Y., Lavikka, K. A., Hietanen, S., Hynninen, J., Haltia, U.-M., Tyrmi, J. S., Laivuori, H., Konstantinopoulos, P. A., Hautaniemi, S., Kauppi, L., & Färkkilä, A. (2022). Optimized detection of homologous recombination deficiency improves the prediction of clinical outcomes in cancer. npj precision oncology, 6(1), Article 96. https://doi.org/10.1038/s41698-022-00339-8

@article{65f87db02c8744f9a07d0f452306e63a,

title = "Optimized detection of homologous recombination deficiency improves the prediction of clinical outcomes in cancer",

keywords = "3122 Cancers",

author = "{Perez Villatoro}, {Fernando Ramon} and Jaana Oikkonen and Julia Casado and Anastasiya Chernenko and Gulhan, {Doga C.} and Manuela Tumiati and Yilin Li and Lavikka, {Kari Antero} and Sakari Hietanen and Johanna Hynninen and Ulla-Maija Haltia and Tyrmi, {Jaakko S.} and Hannele Laivuori and Konstantinopoulos, {Panagiotis A.} and Sampsa Hautaniemi and Liisa Kauppi and Anniina F{\"a}rkkil{\"a}",

year = "2022",

doi = "10.1038/s41698-022-00339-8",

language = "English",

volume = "6",

journal = "npj precision oncology",

issn = "2397-768X",

publisher = "Springer",

number = "1",

}

Perez Villatoro, FR , Oikkonen, J, Casado, J, Chernenko, A, Gulhan, DC, Tumiati, M, Li, Y, Lavikka, KA, Hietanen, S, Hynninen, J, Haltia, U-M, Tyrmi, JS, Laivuori, H, Konstantinopoulos, PA, Hautaniemi, S , Kauppi, L & Färkkilä, A 2022, 'Optimized detection of homologous recombination deficiency improves the prediction of clinical outcomes in cancer', npj precision oncology, vol. 6, no. 1, 96. https://doi.org/10.1038/s41698-022-00339-8

TY - JOUR

T1 - Optimized detection of homologous recombination deficiency improves the prediction of clinical outcomes in cancer

AU - Perez Villatoro, Fernando Ramon

AU - Oikkonen, Jaana

AU - Casado, Julia

AU - Chernenko, Anastasiya

AU - Gulhan, Doga C.

AU - Tumiati, Manuela

AU - Li, Yilin

AU - Lavikka, Kari Antero

AU - Hietanen, Sakari

AU - Hynninen, Johanna

AU - Haltia, Ulla-Maija

AU - Tyrmi, Jaakko S.

AU - Laivuori, Hannele

AU - Konstantinopoulos, Panagiotis A.

AU - Hautaniemi, Sampsa

AU - Kauppi, Liisa

AU - Färkkilä, Anniina

PY - 2022

Y1 - 2022

KW - 3122 Cancers

U2 - 10.1038/s41698-022-00339-8

DO - 10.1038/s41698-022-00339-8

M3 - Article

SN - 2397-768X

VL - 6

JO - npj precision oncology

JF - npj precision oncology

IS - 1

M1 - 96

ER -

Optimized detection of homologous recombination deficiency improves the prediction of clinical outcomes in cancer

Fields of Science

Access to Document

Projects

Discovery and therapeutic exploitation of immunological vulnerabilities in ovarian cancer

Discovery and therapeutic exploitation of immunological vulnerabilities in ovarian cancer

Activities

iCAN Ovarian Cancer Subproject coordinator

Cite this